Tumor angiogenesis requires both upregulation of angiogenic stimulators such as VEGF, bFGF, angiogenin and downregulation of endogenous angiogenic inhibitors such as tumstatin, endostatin and thrombospondin (30). Here, COL18A1 is linked to neoplasm.